18 research outputs found
ARE DISEASE MANAGEMENT PROGRAMS FOR COPD COST-SAVING?
Prevention, Population and Disease management (PrePoD
Exploring the variation in implementation of a COPD disease management programma and its impact on health outcomes
This study aims to (1) examine the variation in implementation of a 2-year chronic obstructive pulmonary disease (COPD) management programme called RECODE, (2) analyse the facilitators and barriers to implementation and (3) investigate the influence of this variation on health outcomes. Implementation variation among the 20 primary-care teams was measured directly using a self-developed scale and indirectly through the level of care integration as measured with the Patient Assessment of Chronic Illness Care (PACIC) and the Assessment of Chronic Illness Care (ACIC). Interviews were held to obtain detailed information regarding the facilitators and barriers to implementation. Multilevel models were used to investigate the association between variation in implementation and change in outcomes. The teams implemented, on average, eight of the 19 interventions, and the specific package of interventions varied widely. Important barriers and facilitators of implementation were (in)sufficient motivation of healthcare provider and patient, the h
The Fold-in, Fold-out Design for DCE Choice Tasks: Application to Burden of Disease
Background. In discrete-choice experiments (DCEs), choice alternatives are described by attributes. The importance
of each attribute can be quantified by analyzing respondents’ choices. Estimates are valid only if alternatives are
defined comprehensively, but choice tasks can become too difficult for respondents if too many attributes are
included. Several solutions for this dilemma have been proposed, but these have practical or theoretical drawbacks
and cannot be applied in all settings. The objective of the current article is to demonstrate an alternative solution, the
fold-in, fold-out approach (FiFo). We use a motivating example, the ABC Index for burden of disease in chronic
obstructive pulmonary disease (COPD). Methods. Under FiFo, all attributes are part of all choice sets, but they are
grouped into domains. These are either folded in (all attributes have the same level) or folded out (levels may differ).
FiFo was applied to the valuation of the ABC Index, which included 15 attributes. The data were analyzed in
Bayesian mixed logit regression, with additional parameters to account for increased complexity in folded-out questionnaires and potential differences in weight due to the folding status of dom
Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial.
__Objective__ To investigate the long term effectiveness of integrated disease management delivered in primary care on quality of life in patients with chronic obstructive pulmonary disease (COPD) compared with usual care.
__Design__ 24 month, multicentre, pragmatic cluster randomised controlled trial
__Setting__ 40 general practices in the western part of the Netherlands
__Participants__ Patients with COPD according to GOLD (Global Initiative for COPD) criteria. Exclusion criteria were terminal illness, cognitive impairment, alcohol or drug misuse, and inability to fill in Dutch questionnaires. Practices were included if they were willing to create a multidisciplinary COPD team.
__Intervention__ General practitioners, practice nurses, and specialised physiotherapists in the intervention group received a two day training course on incorporating integrated disease management in practice, including early recognition of exacerbations and self management, smoking cessation, physiotherapeutic reactivation, optimal diagnosis, and drug adherence. Additionally, the course served as a network platform and collaborating healthcare providers designed an individual practice plan to integrate integrated disease management into daily practice. The control group continued usual care (based on
ABC Index: quantifying experienced burden of COPD in a discrete choice experiment and predicting costs
OBJECTIVE: The Assessment of Burden of COPD (ABC) tool supports shared decision making between patient and caregiver. It includes a coloured balloon diagram to visualise patients' scores on burden indicators. We aim to determine the importance of each indicator from a patient perspective, in order to calculate a weighted index score and investigate whether that score is predictive of costs.DESIGN: Discrete choice experiment.SETTING AND PARTICIPANTS: Primary care and secondary care in the Netherlands. 282 patients with chronic obstructive pulmonary disease (COPD) and 252 members of the general public participated.METHODS: Respondents received 14 choice questions and indicated which of two health states was more severe. Health states were described in terms of specific symptoms, limitations in physical, daily and social activities, mental problems, fatigue and exacerbations, most of which had three levels of severity. Weights for each item-level combination were derived from a Bayesian mixed logit model. Weights were rescaled to construct an index score from 0 (best) to 100 (worst). Regression models were used to find a classification of this index score in mild, moderate and severe that was discriminative in terms of healthcare costs.RESULTS: Fatigue, limitations in moderate physical activities, number of exacerbations, dyspnoea at rest and fear of breathing getting worse contributed most to the burden of disease. Patients assigned less weight to dyspnoea during exercise, listlessness and limitations with regard to strenuous activities. Respondents from the general public mostly agreed. Mild, moderate and severe burden of disease were defined as scores <20, 20-39 and ≥40. This categorisation was most predictive of healthcare utilisation and annual costs: €1368, €2510 and €9885, respectively.CONCLUSIONS: The ABC Index is a new index score for the burden of COPD, which is based on patients' preferences. The classification of the index score into mild, moderate and severe is predictive of future healthcare costs.TRIAL REGISTRATION NUMBER: NTR3788; Post-results